AW
AZN icon

ACG Wealth’s AstraZeneca AZN Stock Holding History

ACG Wealth’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$747K Sell
6,815
-6,502
-49% -$825K 0.17% 135
2022
Q2 		$1.76M Sell
13,317
-321
-2% -$42.1K 0.36% 79
2022
Q1 		$1.81M Sell
13,638
-744
-5% -$89.2K 0.34% 80
2021
Q4 		$1.68M Sell
14,382
-355
-2% -$41.8K 0.24% 99
2021
Q3 		$1.77M Buy
+14,737
New +$1.72M 0.23% 93

Other funds holding AZN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
GQG Partners
GQG Partners Ft. Lauderdale, Florida $63.1B AUM 23.07% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CIBC Private Wealth Group
CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return

ACG Wealth's AZN Position: Q3 2022 in Review

ACG Wealth reduced its AstraZeneca (AZN) stake by 49% in Q3 2022, selling an estimated $825K and leaving 6,815 shares worth $747K. The position accounts for 0.17% of the portfolio, ranked #135.

ACG Wealth first reported a position in AZN in Q3 2021 and has held it in 5 quarters since. The position peaked at $1.81M in Q1 2022. 965 funds tracked by Wall St. Rank hold AZN as of Q3 2022.

  • ACG Wealth held 6,815 shares of AstraZeneca worth $747K as of Q3 2022.
  • ACG Wealth sold 6,502 AstraZeneca shares in Q3 2022, an estimated $825K.
  • AstraZeneca made up 0.17% of ACG Wealth's portfolio in Q3 2022, its #135 holding.
  • ACG Wealth first reported a position in AstraZeneca in Q3 2021 and has held it in 5 quarters since.
  • ACG Wealth's AstraZeneca position peaked at $1.81M in Q1 2022.
  • 965 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2022.

Based on ACG Wealth's 13F filing for Q3 2022, filed 3 Nov 2022.